SURAKSHA
Suraksha Diagnostic Limited (SURAKSHA) Stock Analysis
Suraksha Diagnostic Limited operates pathology laboratories and diagnostic centers offering imaging and testing services. It provides clinical diagnostics to patients and hospitals with growing chain footprint. The company competes in organized diagnostics in eastern and central India. It is listed on Indian stock exchanges.
Healthcare › Diagnostics & Research
₹343.30
+2.45% 1W | +19.20% 52W
Market Cap
1.8k CR
P/E Ratio
49.8
52W High
₹360
52W Low
₹224.1
Div. Yield
0.14%
Beta
–
50 DMA
₹298.6
200 DMA
₹280
Profit Margin
11%
Inst. Own.
22.5%
📊 CONSOLIDATION
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 60 | 52 | 55 | 61 | 67 | 60 | 65 | 73 | 79 | 78 | 81 | 88 |
| Expenses | 39 | 36 | 36 | 40 | 44 | 41 | 46 | 49 | 55 | 55 | 57 | 57 |
| Operating Profit | 21 | 15 | 19 | 21 | 23 | 18 | 19 | 24 | 24 | 23 | 24 | 30 |
| OPM % | 35% | 30% | 35% | 34% | 35% | 31% | 29% | 33% | 31% | 30% | 30% | 35% |
| Other Income | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 4 |
| Depreciation | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 10 | 11 | 11 | 11 |
| Profit before tax | 11 | 6 | 9 | 11 | 14 | 8 | 9 | 12 | 12 | 10 | 10 | 17 |
| Tax % | 24% | 27% | 32% | 27% | 26% | 26% | 22% | 26% | 27% | 28% | 38% | 22% |
| Net Profit | 8 | 5 | 6 | 8 | 10 | 6 | 7 | 9 | 9 | 7 | 6 | 13 |
| EPS in Rs | 121.88 | 67.39 | 94.49 | 1.84 | 2.40 | 1.18 | 1.42 | 1.80 | 1.73 | 1.44 | 1.21 | 2.50 |
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 158 | 140 | 223 | 190 | 219 | 252 | 310 | 325 |
| Expenses | 123 | 115 | 174 | 143 | 146 | 170 | 214 | 223 |
| Operating Profit | 34 | 25 | 49 | 47 | 73 | 82 | 96 | 102 |
| OPM % | 22% | 18% | 22% | 25% | 33% | 33% | 31% | 31% |
| Other Income | 2 | -1 | 1 | 1 | 1 | 4 | 3 | 3 |
| Interest | 2 | 2 | 2 | 10 | 10 | 9 | 13 | 14 |
| Depreciation | 13 | 16 | 15 | 32 | 33 | 35 | 41 | 43 |
| Profit before tax | 21 | 6 | 33 | 7 | 31 | 41 | 45 | 49 |
| Tax % | 28% | -1% | 28% | 10% | 26% | 25% | 30% | |
| Net Profit | 15 | 6 | 24 | 6 | 23 | 31 | 31 | 35 |
| EPS in Rs | 220.43 | 93.33 | 344.20 | 94.49 | 342.46 | 6.11 | 6.18 | 6.88 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 1% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 18.0% | 17.0% | – |
| Profit CAGR | 62.0% | 32.0% | – |
Shareholding Pattern
Promoters48.89%
FIIs13.95%
DIIs22.37%
Public14.79%
Promoters48.98%
FIIs13.73%
DIIs21.98%
Public15.30%
Promoters49.00%
FIIs13.46%
DIIs22.57%
Public14.98%
Promoters49.10%
FIIs13.46%
DIIs23.14%
Public14.31%
Promoters49.10%
FIIs13.47%
DIIs23.22%
Public14.20%
Promoters48.78%
FIIs14.46%
DIIs22.05%
Public14.71%
Promoters49.10%
FIIs13.46%
DIIs23.14%
Public14.31%
Promoters49.10%
FIIs13.47%
DIIs23.22%
Public14.20%
SURAKSHA
Holdings Analysis
Key strengths & risk signals
83
Overall
86
Fundamental
81
Technical
Risks (1)
NEGLIGIBLE DIVIDEND! 0.14% yield - little to no income.
Strengths (4)
UNDERVALUED! PEG of 0.71 indicates stock is cheap relative to growth.
BULLISH TREND! 50-day average (298.6) is above 200-day average (280.0) - positive signal.
BULLISH SENTIMENT! In last 30 days: 18 up days, 12 down days. Avg volume on up days: 403,810 vs down days: 99,020. Ratio: 4.08x
STRONG! Trading at 87.7% of 52W range - near yearly highs.
Fundamental & Technical Analysis
83Overall
86Fundamental
81Technical
Fundamental Breakdown
Growth Quality
28/30
Revenue CAGR: 17.7% (VERY GOOD, 13/15). Profit CAGR: 70.3% (EXCELLENT, 15/15).
Profit Margin
5/10
DECENT EFFICIENCY! 11.0% profit margin - acceptable profitability.
PEG Valuation
10/10
UNDERVALUED! PEG of 0.71 indicates stock is cheap relative to growth.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.14% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
20/20
VERY LESS PUBLIC HOLDING! 15.39% public ownership - strong promoter/institutional control.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (298.6) is above 200-day average (280.0) - positive signal.
Price Position
8/10
STRONG POSITION! Current price (343.3) is above both moving averages.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
6/10
POSITIVE YEAR! Stock gained 19.2% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 18 up days, 12 down days. Avg volume on up days: 403,810 vs down days: 99,020. Ratio: 4.08x
RSI
3/5
BULLISH! RSI at 62.0 - positive momentum.
52W Range
5/5
STRONG! Trading at 87.7% of 52W range - near yearly highs.
Momentum
4/5
GOOD MOMENTUM! Price has grown across all timeframes - up 2.5% (1 week), 1.3% (1 month), 26.4% (3 months).
Beta
3/5
MARKET ALIGNED! Beta of 1.00 - moves with the market.
SURAKSHA
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q4FY262026-05-27 | Concall PDF | |
| Q3FY262026-02-12 | Concall PDF | |
| Q2FY262025-11-14 | Concall PDF |
Peer Comparison
Healthcare · Diagnostics & Research · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SURAKSHA | ₹343.30 | 49.8 | 11.0% | 17.7% | 70.3% | +19.2% | 83 | BREAKDOWN | +38.3% | +106.3% | +20.7% | +7.6% |
| KRSNAA | ₹548.50 | 18.5 | 11.6% | 16.6% | 17.8% | -29.4% | 64 | APPROACHING SUPPORT | -19.0% | -60.2% | +22.0% | +22.3% |
| VIMTALABS | ₹599.30 | 34.3 | 18.9% | 8.9% | 17.2% | -18.0% | 65 | BREAKDOWN | +11.1% | -0.5% | +11.8% | -0.1% |
| THYROCARE | ₹566.90 | 51.4 | 20.1% | 16.7% | 36.2% | +51.2% | 87 | BOUNCE FROM SUPPORT | +34.2% | +10.8% | +24.4% | +7.1% |
| METROPOLIS | ₹582.60 | 59.8 | 11.8% | 12.8% | 10.0% | +16.3% | 67 | APPROACHING RESISTANCE | +25.7% | +11.4% | +16.6% | +6.0% |
| SYNGENE | ₹378.70 | 69.1 | 6.1% | 5.4% | -12.0% | -37.6% | 51 | APPROACHING SUPPORT | -110.4% | -106.1% | -15.8% | -29.0% |
| VIJAYA | ₹1,513.60 | 83.3 | 21.9% | 21.0% | 26.9% | +49.7% | 84 | CONSOLIDATION | +37.6% | +10.9% | +22.8% | +5.3% |
| LALPATHLAB | ₹1,952.30 | 60.3 | 18.7% | 11.1% | 28.3% | +22.8% | 87 | BREAKDOWN | +28.0% | +29.1% | +19.1% | +13.5% |
Data from TradeAlone · Updated daily
